<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Infantile hemangiomas: Evaluation and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Infantile hemangiomas: Evaluation and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Infantile hemangiomas: Evaluation and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Denise W Metry, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Moise L Levy, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 08, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infantile hemangiomas are benign tumors of vascular endothelium and the most common tumors of childhood [
         <a href="#rid1">
          1
         </a>
         ]. Despite their benign and self-limited nature, some hemangiomas can cause complications, such as ulceration or life-altering disfigurement. Occasionally, hemangiomas may compromise vital organ function or may occur in association with developmental anomalies.
        </p>
        <p>
         The evaluation of infantile hemangiomas will be discussed here. The epidemiology, pathogenesis, clinical features, complications, and management of infantile hemangiomas are discussed separately. PHACE (
         <strong>
          p
         </strong>
         osterior fossa anomalies,
         <strong>
          h
         </strong>
         emangioma,
         <strong>
          a
         </strong>
         rterial anomalies,
         <strong>
          c
         </strong>
         ardiac anomalies, and
         <strong>
          e
         </strong>
         ye anomalies) syndrome is also discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5794.html" rel="external">
          "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5792.html" rel="external">
          "Infantile hemangiomas: Management"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13735.html" rel="external">
          "PHACE syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the vast majority of cases, the diagnosis of a hemangioma can be established clinically, based upon the history and physical examination [
         <a href="#rid2">
          2
         </a>
         ]. However, deeper, subcutaneous lesions without the characteristic overlying skin changes and hepatic lesions (especially in the absence of a cutaneous hemangioma) may be very difficult to distinguish from vascular malformations or other tumors. Although imaging studies can be helpful [
         <a href="#rid3">
          3-6
         </a>
         ], tissue biopsy is generally needed for definitive diagnosis in cases that are atypical in appearance or behavior.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          History
         </span>
         <span class="headingEndMark">
          —
         </span>
         Important aspects of the history for a child with a vascular lesion include [
         <a href="#rid7">
          7
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Age at which the lesion was first noted and subsequent behavior of the lesion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Presence of ulceration, pain, bleeding, and/or evidence of secondary infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Whether any imaging studies, biopsies, or other prior evaluations (including subspecialty) have been performed.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Previous treatment and response.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of progressive respiratory difficulty in the first several months of life, particularly if a hemangioma is in a cervicofacial or mandibular ("beard") distribution  (
         <a class="graphic graphic_picture graphicRef58168" href="/z/d/graphic/58168.html" rel="external">
          picture 1
         </a>
         ) (may indicate the simultaneous presence of airway hemangioma).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Signs of high-output cardiac failure during early infancy in the presence of multiple (five or more) cutaneous hemangiomas (may indicate the presence of hepatic hemangiomas). (See
         <a class="local">
          'Multiple cutaneous hemangiomas'
         </a>
         below and
         <a class="local">
          'Hepatic hemangiomas'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rapid growth, along with tenseness, purpuric appearance, or widespread telangiectasias, in the presence of a very low platelet count (may indicate the Kasabach-Merritt phenomenon in the case of a kaposiform hemangioendothelioma or tufted angioma [vascular tumors distinct from infantile hemangiomas]). (See
         <a class="medical medical_review" href="/z/d/html/86314.html" rel="external">
          "Tufted angioma, kaposiform hemangioendothelioma (KHE), and Kasabach-Merritt phenomenon (KMP)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Any parental preconceptions: What have they already learned about the potential diagnosis and treatment options? What concerns them the most about their child's lesion(s)?
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         The physical examination should include [
         <a href="#rid7">
          7
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Careful examination of the skin and mucous membranes
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Documentation of lesion morphology, location, and approximate size
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Documentation of the presence and severity of ulceration and whether there is clinical evidence of secondary infection
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Palpation of the abdomen for hepatomegaly and evaluation for abdominal bruit if clinically indicated, including evaluation for signs of high-output heart failure (eg, tachycardia, wide pulse pressure, bounding pulses, midsystolic murmur, and/or a third heart sound caused by the increased rate of ventricular filling) (see
         <a class="medical medical_review" href="/z/d/html/2860.html" rel="external">
          "The pediatric physical examination: Chest and abdomen"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Imaging studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most hemangiomas can be diagnosed clinically without additional studies. In the minority of cases where the diagnosis is in question, imaging (ultrasonography, computed tomography [CT], or magnetic resonance imaging [MRI]) can be helpful but should not be relied upon if there is any question of malignancy, in which case tissue biopsy is generally necessary. Clinical findings that may raise suspicion of malignancy include lesion present at birth, firm texture on palpation, tenderness (unless ulcerated), and rapid enlargement.
        </p>
        <p>
         Imaging may also be useful in evaluating the extent of a complicated hemangioma, evaluating for other potential anomalies when clinically indicated (eg, PHACE [
         <strong>
          p
         </strong>
         osterior fossa anomalies,
         <strong>
          h
         </strong>
         emangioma,
         <strong>
          a
         </strong>
         rterial anomalies,
         <strong>
          c
         </strong>
         ardiac anomalies, and
         <strong>
          e
         </strong>
         ye anomalies] syndrome, LUMBAR [
         <strong>
          l
         </strong>
         ower-body hemangioma and other cutaneous defects,
         <strong>
          u
         </strong>
         rogenital anomalies,
         <strong>
          u
         </strong>
         lceration,
         <strong>
          m
         </strong>
         yelopathy,
         <strong>
          b
         </strong>
         ony deformities,
         <strong>
          a
         </strong>
         norectal malformations,
         <strong>
          a
         </strong>
         rterial anomalies, and
         <strong>
          r
         </strong>
         enal anomalies] syndrome), or following response to therapy, particularly in the case of hepatic hemangiomas. (See
         <a class="local">
          'Additional evaluation'
         </a>
         below and
         <a class="local">
          'Differential diagnosis'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          ADDITIONAL EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Depending upon the location and morphology of the hemangioma, additional evaluation and/or referral to an appropriate and experienced vascular anomalies specialist may be necessary for children in whom the diagnosis of infantile hemangioma is in question and for those who have actual or potential organ complications, particularly when the lesion is segmental. Early referral, ideally between four and six weeks of life, is also indicated for infants with high-risk hemangiomas for whom systemic therapy is being considered [
         <a href="#rid8">
          8
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5792.html" rel="external">
          "Infantile hemangiomas: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3750593008">
         <span class="h2">
          Infantile hemangiomas with minimal or arrested growth
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infantile hemangiomas with minimal or arrested growth (IH-MAGs) are an uncommon variant of infantile hemangiomas, presenting as sharply demarcated, erythematous or bluish patches with one or multiple fine and coarse telangiectasias, venules, and perilesional blanching. Small, proliferative components most commonly develop at the lesion edge, providing a clue to the diagnosis of infantile hemangiomas  (
         <a class="graphic graphic_picture graphicRef65721" href="/z/d/graphic/65721.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid9">
          9-11
         </a>
         ].
        </p>
        <p>
         In contrast with typical infantile hemangiomas, IH-MAGs exhibit minimal growth after birth. They preferentially affect the distal limbs but can also occur on the face and lumbosacral area and may be mistaken for port wine stains. On immunohistochemistry, they stain positive for glucose transporter 1 (GLUT-1), supporting their diagnosis as true infantile hemangiomas that simply lack a significant proliferative phase [
         <a href="#rid12">
          12
         </a>
         ]. IH-MAGs will also involute the same as classic infantile hemangiomas.
        </p>
        <p>
         Large, segmental IH-MAGs may warrant further investigation for internal organ involvement. Segmental forms located on the face have been described in infants with PHACE (
         <strong>
          p
         </strong>
         osterior fossa anomalies,
         <strong>
          h
         </strong>
         emangioma,
         <strong>
          a
         </strong>
         rterial anomalies,
         <strong>
          c
         </strong>
         ardiac anomalies, and
         <strong>
          e
         </strong>
         ye anomalies) syndrome and LUMBAR (
         <strong>
          l
         </strong>
         ower-body hemangioma and other cutaneous defects,
         <strong>
          u
         </strong>
         rogenital anomalies,
         <strong>
          u
         </strong>
         lceration,
         <strong>
          m
         </strong>
         yelopathy,
         <strong>
          b
         </strong>
         ony deformities,
         <strong>
          a
         </strong>
         norectal malformations,
         <strong>
          a
         </strong>
         rterial anomalies, and
         <strong>
          r
         </strong>
         enal anomalies) syndrome [
         <a href="#rid13">
          13,14
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/13735.html" rel="external">
          "PHACE syndrome"
         </a>
         and
         <a class="local">
          'LUMBAR syndrome'
         </a>
         below). Moreover, segmental IH-MAGs involving the extremities have also been associated with persisting underlying soft tissue hypertrophy [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Periorbital hemangiomas
         </span>
         <span class="headingEndMark">
          —
         </span>
         Periorbital hemangiomas may compromise normal visual development  (
         <a class="graphic graphic_picture graphicRef126983" href="/z/d/graphic/126983.html" rel="external">
          picture 3
         </a>
         ). In concerning cases (eg, hemangiomas obstructing vision), early examination by an ophthalmologist familiar with the evaluation and treatment of periorbital hemangiomas is mandatory [
         <a href="#rid16">
          16
         </a>
         ]. Hemangiomas that are located on the upper eyelid, greater than 1 cm, and have a deep component are at greatest risk of astigmatism and amblyopia [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Patients with large, segmental hemangiomas of the face may also be at risk for PHACE syndrome and require further evaluation. (See
         <a class="local">
          'Segmental hemangiomas'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/13735.html" rel="external">
          "PHACE syndrome"
         </a>
         .)
        </p>
        <p>
         The management of periorbital hemangiomas is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5792.html" rel="external">
          "Infantile hemangiomas: Management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Segmental hemangiomas
         </span>
         <span class="headingEndMark">
          —
         </span>
         Segmental hemangiomas are usually plaque-like and demonstrate linear and/or geographic patterning  (
         <a class="graphic graphic_picture graphicRef82212" href="/z/d/graphic/82212.html" rel="external">
          picture 4
         </a>
         ) [
         <a href="#rid18">
          18,19
         </a>
         ]. Segmental hemangiomas of the face or scalp may be associated with PHACE syndrome, and those overlying the lumbosacral spine, pelvis, and/or lower extremities may be associated with LUMBAR syndrome and should be evaluated accordingly. (See
         <a class="medical medical_review" href="/z/d/html/13735.html" rel="external">
          "PHACE syndrome"
         </a>
         .)
        </p>
        <p>
         Similar to multiple (≥5) cutaneous hemangiomas, segmental hemangiomas may also be associated with visceral hemangiomatosis [
         <a href="#rid20">
          20,21
         </a>
         ]. The locations of visceral lesions often correlate regionally with the sites of cutaneous lesions. Visceral hemangiomas undergo spontaneous involution, as do their cutaneous counterparts, probably most often without sequelae, and are rarely clinically symptomatic. For this reason, evaluation of infants with segmental hemangiomas depends upon the anatomic location and, most importantly, the presence of clinical signs and symptoms [
         <a href="#rid21">
          21
         </a>
         ]. Imaging of asymptomatic
         <strong>
         </strong>
         infants with segmental hemangiomas for visceral hemangiomatosis is
         <strong>
          not
         </strong>
         recommended because of the expense and usual need for general anesthesia in young infants.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Beard distribution
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants with segmental,
         <strong>
          bilateral
         </strong>
         , cervicofacial or mandibular hemangiomas in a "beard" distribution  (
         <a class="graphic graphic_picture graphicRef58168" href="/z/d/graphic/58168.html" rel="external">
          picture 1
         </a>
         ) should be clinically monitored for signs of airway involvement (eg, progressive hoarseness, stridor) [
         <a href="#rid22">
          22
         </a>
         ]. The possibility of PHACE syndrome should also be considered in these patients. (See
         <a class="medical medical_review" href="/z/d/html/5794.html" rel="external">
          "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications", section on 'Complications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13165020">
         <span class="h3">
          PHACE syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants with large (&gt;5 cm in diameter), segmental hemangiomas, particularly when located on the face or scalp, are at risk for PHACE (
         <strong>
          p
         </strong>
         osterior fossa anomalies,
         <strong>
          h
         </strong>
         emangioma,
         <strong>
          a
         </strong>
         rterial anomalies,
         <strong>
          c
         </strong>
         ardiac anomalies, and
         <strong>
          e
         </strong>
         ye anomalies) syndrome  (
         <a class="graphic graphic_table graphicRef80245" href="/z/d/graphic/80245.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef70599" href="/z/d/graphic/70599.html" rel="external">
          picture 5
         </a>
         ) [
         <a href="#rid23">
          23-25
         </a>
         ]. These infants should undergo careful cutaneous, ophthalmologic, cardiovascular, neurovascular, and neurologic evaluations [
         <a href="#rid26">
          26,27
         </a>
         ]. The clinical features, diagnosis, evaluation, and management of PHACE syndrome are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13735.html" rel="external">
          "PHACE syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          LUMBAR syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         LUMBAR (
         <strong>
          l
         </strong>
         ower-body hemangioma and other cutaneous defects,
         <strong>
          u
         </strong>
         rogenital anomalies,
         <strong>
          u
         </strong>
         lceration,
         <strong>
          m
         </strong>
         yelopathy,
         <strong>
          b
         </strong>
         ony deformities,
         <strong>
          a
         </strong>
         norectal malformations,
         <strong>
          a
         </strong>
         rterial anomalies, and
         <strong>
          r
         </strong>
         enal anomalies) syndrome defines the association of segmental hemangiomas over the lower half of the body  (
         <a class="graphic graphic_picture graphicRef72298" href="/z/d/graphic/72298.html" rel="external">
          picture 6
         </a>
         ) with several underlying anomalies, including tethered spinal cord, lipomyelomeningocele, bony anomalies of the sacrum, abnormal genitalia, imperforate anus with fistula formation, or renal abnormalities [
         <a href="#rid28">
          28-36
         </a>
         ].
        </p>
        <p>
         LUMBAR syndrome is considered the "lower half of the body" counterpart to PHACE syndrome. MRI is the most sensitive means of definitive diagnosis of spinal anomalies and should be performed in all infants or older children with a segmental hemangioma over the lumbosacral spine. Screening for additional anomalies associated with LUMBAR syndrome is determined on a case-by-case basis as clinically indicated.
        </p>
        <p>
         Screening of patients with midline hemangiomas in the lumbosacral area is supported by the results of a multicenter, prospective, cohort study [
         <a href="#rid37">
          37
         </a>
         ]. In this study, MRI detected spinal anomalies in 21 out of 41 children (51 percent) with localized or segmental, lumbosacral hemangiomas that were greater than or equal to 2.5 cm in size (risk ratio [RR] 640, 95% CI 404-954). The study did not evaluate imaging in patients with smaller lesions, and it is unclear whether these results translate to patients with small, localized hemangiomas. A retrospective study evaluated the types of spinal dysraphism in children with lumbosacral hemangioma [
         <a href="#rid34">
          34
         </a>
         ]. Among 20 children with lumbosacral hemangioma and spinal dysraphism, 12 had tethered cord, 10 had spinal lipoma or lipomyelomeningocele, 9 had intraspinal hemangiomas, and 8 had sinus tract [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         Unlike MRI, ultrasonographic examination does not require sedation in infants. Some authors have suggested that ultrasonography can be performed instead of MRI in infants younger than four months of age if expertise in pediatric ultrasonography is available [
         <a href="#rid29">
          29,30,32
         </a>
         ]. However, ultrasounds may miss some spinal abnormalities. In the cohort study described above, 5 out of 12 patients (42 percent) with normal ultrasound examinations were subsequently noted to have spinal anomalies on MRI [
         <a href="#rid37">
          37
         </a>
         ]. The average age of patients who received ultrasounds in the study was two months. The sensitivity and specificity of ultrasonography were 50 percent (95% CI 19-81) and 78 percent (95% CI 40-97), respectively. Another prospective study also found that ultrasounds failed to detect spinal dysraphism in some patients; the diagnosis was missed in 15 percent of infants under the age of six months who had hemangiomas or lipomas overlying the involved area [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         Therefore, MRI remains the gold standard for evaluating patients with lumbosacral hemangiomas for underlying spinal disorders. In young infants, ultrasonography can be used as an initial test, and MRI can be delayed until the age of four to six months if there are no clinical findings that indicate the need for earlier evaluation (patent sinus tracts, ulceration, or neurologic signs or symptoms) [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Multiple cutaneous hemangiomas
         </span>
         <span class="headingEndMark">
          —
         </span>
         Approximately 30 percent of infants have more than one hemangioma, but only 3 percent have six or more lesions [
         <a href="#rid39">
          39
         </a>
         ]. Multifocal cutaneous hemangiomas at risk for concomitant visceral hemangiomas (ie, diffuse neonatal hemangiomatosis) are defined as ≥5 small, localized lesions.
        </p>
        <p class="headingAnchor" id="H1441103234">
         <span class="h3">
          Hepatic hemangiomas
         </span>
        </p>
        <p class="headingAnchor" id="H2247528925">
         <span class="h4">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         In infants with multiple cutaneous hemangiomas, the liver is the extracutaneous site most frequently involved, whereas involvement of other sites, such as the gastrointestinal tract or the brain, is rare. Hepatic hemangiomas most often occur as multifocal or, rarely, diffuse lesions [
         <a href="#rid40">
          40,41
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Focal lesions are most often not true infantile hemangiomas but instead represent rapidly involuting congenital hemangiomas, which are fully developed at birth and are occasionally detected prenatally by routine ultrasound [
         <a href="#rid40">
          40,41
         </a>
         ]. Like their cutaneous counterpart, they typically rapidly involute after birth, with their size reduced by approximately 80 percent by the age of 12 or 13 months [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13727.html" rel="external">
          "Congenital hemangiomas: Rapidly involuting congenital hemangioma (RICH), noninvoluting congenital hemangioma (NICH), and partially involuting congenital hemangioma (PICH)", section on 'Hepatic rapidly involuting congenital hemangiomas'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multifocal hepatic hemangiomas are usually associated with multiple cutaneous hemangiomas and are generally detected by screening or routine abdominal ultrasound examination (see
         <a class="local">
          'Screening'
         </a>
         below). Multifocal lesions increase in size throughout the proliferative phase (between the neonatal period and the age of approximately six months) and then gradually involute. Also similar to cutaneous infantile hemangiomas, involution is often complete by the age of four to five years, on average. During the proliferative phase, due to increased arteriovenous shunting, infants may develop signs of high-output cardiac failure and consumptive hypothyroidism, due to increased expression of type 3 iodothyronine deiodinase, which inactivates the thyroid hormone.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diffuse lesions are characterized by a nearly complete replacement of the liver parenchyma with hemangioma tissue, leading to serious complications with increased mortality risk, including [
         <a href="#rid42">
          42
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         High volume arteriovenous shunting and cardiac failure
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bleeding and abdominal compartment syndrome
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Liver failure
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2619319717">
         <span class="h4">
          Screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is general consensus among experts that infants presenting with multiple cutaneous hemangiomas should undergo imaging evaluation for hepatic hemangiomas [
         <a href="#rid41">
          41
         </a>
         ]. Doppler ultrasound of the liver is the preferred imaging at initial presentation. Small hepatic hemangiomas (&lt;3 cm) typically appear as a uniformly, hypo- or hyperechoic mass, while larger lesions may contain calcifications, cystic spaces, and sclerotic areas [
         <a href="#rid41">
          41
         </a>
         ]. If the diagnosis is unclear, liver MRI study with contrast and dynamic acquisition pattern can be considered:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It is generally recommended that infants
         <strong>
          &lt;6 months
         </strong>
         with ≥5 cutaneous hemangiomas undergo early evaluation with abdominal ultrasound and be monitored clinically [
         <a href="#rid43">
          43-45
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         This recommendation is supported by a multicenter study of 151 infants with ≥5 hemangiomas in which 24 (16 percent) had solitary or multiple hepatic hemangiomas and 2 (1.3 percent) had airway or gastrointestinal hemangiomas, while none of the children with ≤4 cutaneous hemangiomas had visceral lesions [
         <a href="#rid46">
          46
         </a>
         ]. Only one child with hepatic hemangioma was symptomatic with hepatomegaly and high-output congestive heart failure and required treatment with
         <a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">
          propranolol
         </a>
         and oral corticosteroids.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infants with &lt;5 cutaneous hemangiomas do not require further visceral evaluation or monitoring if findings on physical examination are otherwise normal [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infants with &lt;5 cutaneous hemangiomas who present with hepatomegaly and/or symptoms of cardiac failure (eg, tachypnea, poor feeding, lethargy) should be evaluated for hepatic hemangiomas regardless.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a retrospective, single-center, tertiary, referral study including 843 infants (median age six months) with multiple (83 percent) or solitary cutaneous hemangiomas, 71 of 381 infants who were screened by ultrasound (19 percent) had hepatic hemangiomas [
         <a href="#rid48">
          48
         </a>
         ]. Of patients with hepatic hemangioma, approximately one-third had &lt;5 cutaneous hemangiomas. Eight of 843 patients (&lt;1 percent) required treatment for cardiac failure, and six required treatment for hypothyroidism. Six of these 13 patients requiring treatment had &lt;5 cutaneous hemangiomas. All infants treated for cardiac failure were symptomatic at first presentation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infants
         <strong>
          &gt;6 months
         </strong>
         who are otherwise healthy do not require additional evaluation and monitoring.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infants with diffuse hepatic hemangiomas or with multiple hepatic hemangiomas who show signs or symptoms of hypothyroidism should also be screened for hypothyroidism. Hepatic hemangiomas can cause consumption hypothyroidism through the production of type 3 iodothyronine deiodinase, which is a thyroid-deactivating enzyme [
         <a href="#rid49">
          49,50
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H194744523">
         <span class="h4">
          Monitoring
         </span>
         <span class="headingEndMark">
          —
         </span>
         Expert consensus-based guidelines for monitoring infantile hepatic hemangiomas recommend [
         <a href="#rid41">
          41,42
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Liver ultrasound at progressively longer intervals, with an initial two-week interval, adding two weeks to the interval after each stable evaluation. However, the frequency of monitoring may be individualized, based on the degree of liver involvement and whether treatment is implemented.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Continue monitoring until hemangioma involution is complete.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diffuse, hepatic infantile hemangiomas at higher risk of complications and mortality require more frequent monitoring and a longer follow-up period.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thyroid function tests (thyroid-stimulating hormone [TSH] and free thyroxine [T4]) should be obtained at the time of diagnosis and then repeated monthly in diffuse disease at least until the age of six months (approximately end of proliferation period).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Echocardiogram should be considered if there are signs of cardiac failure or ultrasonographic evidence of shunting or massive flow (enlarged hepatic veins).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Large hemangiomas
         </span>
         <span class="headingEndMark">
          —
         </span>
         An increased risk for hepatic hemangiomas in infants with large hemangiomas has been suggested in two, small, retrospective studies [
         <a href="#rid21">
          21,51
         </a>
         ]. In contrast, a prospective study found no hepatic hemangiomas in 60 infants with at least one hemangioma &gt;30 cm
         <sup>
          2
         </sup>
         [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
         Infants with large hemangiomas do not need to be routinely screened for hepatic hemangiomas with ultrasonography purely based upon lesion size. However, if signs or symptoms that suggest hepatic hemangiomas (poor growth or feeding, tachypnea, cardiac murmur, abdominal distension, or hepatomegaly) are present, referral for evaluation and monitoring is indicated [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="local">
          'Hepatic hemangiomas'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         As mentioned above, the diagnosis of infantile hemangiomas can be made on the basis of history and physical examination in the vast majority of cases (see
         <a class="local">
          'Diagnosis'
         </a>
         above). Cases in which the differential diagnosis may be difficult include [
         <a href="#rid53">
          53
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cutaneous hemangiomas
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Capillary malformation
         </strong>
         – In approximately one-third of cases, infantile hemangioma is present at birth as a macular, telangiectatic patch  (
         <a class="graphic graphic_picture graphicRef89391" href="/z/d/graphic/89391.html" rel="external">
          picture 7
         </a>
         ) similar in appearance to a capillary malformation (ie, port wine stain) [
         <a href="#rid28">
          28
         </a>
         ]. Hemangiomas with this presentation often have surrounding pallor representing vasoconstriction, which can help to differentiate them from capillary malformations early on. In addition, in contrast with capillary malformations, hemangiomas quickly begin to develop small, vascular blebs and become raised. Early arteriovenous malformations of the skin can also present as a cutaneous "blush" that is sometimes initially misdiagnosed as an infantile hemangioma. (See
         <a class="medical medical_review" href="/z/d/html/13726.html" rel="external">
          "Capillary malformations (port wine birthmarks) and associated syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Congenital hemangiomas and vascular malformations
         </strong>
         – Large, vascular lesions that are congenital (ie, "fully developed" at birth) are very unlikely to be true infantile hemangiomas, which are characterized by proliferation
         <strong>
          after
         </strong>
         birth. These include rapidly involuting or noninvoluting congenital "hemangiomas"  (
         <a class="graphic graphic_picture graphicRef88803 graphicRef88907" href="/z/d/graphic/88803.html" rel="external">
          picture 8A-B
         </a>
         ), other benign and malignant vascular tumors, and vascular malformations, diagnoses that can often be made clinically by a specialist familiar with such entities [
         <a href="#rid28">
          28,54,55
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13727.html" rel="external">
          "Congenital hemangiomas: Rapidly involuting congenital hemangioma (RICH), noninvoluting congenital hemangioma (NICH), and partially involuting congenital hemangioma (PICH)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/110155.html" rel="external">
          "Venous malformations"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Kaposiform hemangioendothelioma and tufted hemangioma
         </strong>
         – Rapidly proliferating, violaceous tumors in the setting of the Kasabach-Merritt phenomenon are not infantile hemangiomas but one of two other histologically benign, but sometimes aggressive, vascular tumors: kaposiform hemangioendothelioma (most commonly  (
         <a class="graphic graphic_picture graphicRef89343" href="/z/d/graphic/89343.html" rel="external">
          picture 9
         </a>
         )) or tufted angioma  (
         <a class="graphic graphic_picture graphicRef89065" href="/z/d/graphic/89065.html" rel="external">
          picture 10
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/86314.html" rel="external">
          "Tufted angioma, kaposiform hemangioendothelioma (KHE), and Kasabach-Merritt phenomenon (KMP)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Subcutaneous tumors
         </strong>
         – Deep, subcutaneous tumors, particularly when no overlying skin changes are present to assist with diagnosis, should be suspect, as should any vascular lesion with an atypical clinical appearance or unusual behavior. Although imaging may be helpful, tissue biopsy is generally necessary in concerning cases in order to exclude malignancy. (See
         <a class="medical medical_review" href="/z/d/html/5788.html" rel="external">
          "Skin nodules in newborns and infants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pyogenic granuloma
         </strong>
         – Pyogenic granuloma is a small (often less than 1 cm), benign vascular tumor of skin and mucosa characterized by rapid growth and a friable surface that easily bleeds  (
         <a class="graphic graphic_picture graphicRef67395" href="/z/d/graphic/67395.html" rel="external">
          picture 11
         </a>
         ). Pyogenic granuloma typically develops on the face or upper trunk in preschool- or school-aged children but is rare in infants [
         <a href="#rid56">
          56,57
         </a>
         ]. Multiple grouped pyogenic granuloma-like lesions may develop in infants and young children over a pre-existing vascular malformation, particularly capillary or arteriovenous malformations [
         <a href="#rid58">
          58
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13736.html" rel="external">
          "Pyogenic granuloma (lobular capillary hemangioma)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other cutaneous lesions that can occasionally mimic infantile hemangiomas include plexiform neurofibroma, infantile fibrosarcoma, dermatofibrosarcoma protuberans, rhabdomyosarcoma, nasal glioma, dermoid cysts, and infantile myofibroma [
         <a href="#rid7">
          7,53,59
         </a>
         ]. These lesions generally have a distinct clinical and histologic appearance. (See
         <a class="medical medical_review" href="/z/d/html/5788.html" rel="external">
          "Skin nodules in newborns and infants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hepatic infantile hemangiomas
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Congenital hemangiomas
         </strong>
         – Focal hepatic hemangiomas are most often rapidly involuting congenital hemangiomas (RICHs) or, rarely, noninvoluting congenital hemangiomas (NICHs). They do not have associated skin lesions, are generally asymptomatic (except hepatomegaly for large lesions), and show no signs of enlargement after birth. Hepatic RICHs, like their cutaneous counterpart, tend to spontaneously regress in the first 12 to 14 months of life, while NICHs do not change significantly in size over time [
         <a href="#rid41">
          41
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13727.html" rel="external">
          "Congenital hemangiomas: Rapidly involuting congenital hemangioma (RICH), noninvoluting congenital hemangioma (NICH), and partially involuting congenital hemangioma (PICH)", section on 'Hepatic rapidly involuting congenital hemangiomas'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Other tumors
         </strong>
         – Hepatic hemangiomas may be very difficult to distinguish from vascular malformations and other benign and malignant infantile liver tumors, including mesenchymal hamartoma, hepatoblastoma, and metastatic neuroblastoma, especially in infants without cutaneous hemangiomas [
         <a href="#rid40">
          40,60
         </a>
         ]. Imaging studies and biopsy for histopathologic examination are required for accurate diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/6810.html" rel="external">
          "Fetal abdomen: Differential diagnosis of abnormal echogenicity and calcification", section on 'Mesenchymal hamartoma'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/130011.html" rel="external">
          "Overview of hepatoblastoma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5187.html" rel="external">
          "Clinical presentation, diagnosis, and staging evaluation of neuroblastoma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4257913636">
         <span class="h1">
          ONLINE RESOURCES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Information for patients and families on infantile hemangioma can be found online at
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fpedsderm.net%2Fsite%2Fassets%2Ffiles%2F1028%2F2_spd_infantile_hemangiomas_web_final.pdf&amp;token=FKGIx0C7d3I1oSpPVwJISuj65sXrk52J888ZNT89R2XTpjT4xkOtqmqLz%2F7aPRpYEzj1m7yJQLwtHSdgZQaH5Xfqz8u7A0wShDOpI2NWKeivALUkLBSw0hah5bEtTSir&amp;TOPIC_ID=5793" target="_blank">
          The Society for Pediatric Dermatology
         </a>
         and the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.hemangiomaeducation.org%2F&amp;token=sL%2Bp%2BgWoM5K8OZ3TcR7z2bhvqwZItHgxgnEt82nVsnmPNl%2B9KEHtpR%2F0iu9bQ1fB&amp;TOPIC_ID=5793" target="_blank">
          Hemangioma Investigator Group
         </a>
         .
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2076857162">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/120263.html" rel="external">
          "Society guideline links: Infantile hemangiomas and PHACE syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – In most cases, the diagnosis of a hemangioma can be established clinically, based on history and physical examination. Deeper, subcutaneous lesions may be difficult to distinguish from vascular malformations or other tumors and may require imaging studies and/or a biopsy for histopathologic examination. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Referral
         </strong>
         – Referral to an appropriate and experienced vascular anomalies specialist is indicated for children in whom the diagnosis is in question and those who have actual or potential organ complications, particularly when the lesion is segmental. Early referral, ideally between four and six weeks of life, is also indicated for infants for whom systemic therapy is being considered (see
         <a class="local">
          'Additional evaluation'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5792.html" rel="external">
          "Infantile hemangiomas: Management"
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Periorbital hemangiomas
         </strong>
         – Infants with periorbital hemangiomas at risk for visual compromise  (
         <a class="graphic graphic_picture graphicRef126983" href="/z/d/graphic/126983.html" rel="external">
          picture 3
         </a>
         ) should be referred to an ophthalmologist familiar with the evaluation and treatment of periorbital hemangiomas. (See
         <a class="local">
          'Periorbital hemangiomas'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Segmental hemangiomas
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Face and scalp
         </strong>
         – Infants with large (&gt;5 cm in diameter), segmental hemangiomas, particularly when located on the face, scalp, or posterior neck  (
         <a class="graphic graphic_picture graphicRef70599" href="/z/d/graphic/70599.html" rel="external">
          picture 5
         </a>
         ), are at risk for PHACE (
         <strong>
          p
         </strong>
         osterior fossa anomalies,
         <strong>
          h
         </strong>
         emangioma,
         <strong>
          a
         </strong>
         rterial anomalies,
         <strong>
          c
         </strong>
         ardiac anomalies, and
         <strong>
          e
         </strong>
         ye anomalies) syndrome  (
         <a class="graphic graphic_table graphicRef80245" href="/z/d/graphic/80245.html" rel="external">
          table 1
         </a>
         ) and should undergo careful cutaneous, ophthalmologic, cardiac, and neurologic evaluations. (See
         <a class="medical medical_review" href="/z/d/html/13735.html" rel="external">
          "PHACE syndrome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Lower body
         </strong>
         – Infants with segmental hemangiomas over the lower half of the body  (
         <a class="graphic graphic_picture graphicRef72298" href="/z/d/graphic/72298.html" rel="external">
          picture 6
         </a>
         ) should be evaluated with MRI for underlying spinal dysraphism and other anomalies that define the LUMBAR (
         <strong>
          l
         </strong>
         ower-body hemangioma and other cutaneous defects,
         <strong>
          u
         </strong>
         rogenital anomalies,
         <strong>
          u
         </strong>
         lceration,
         <strong>
          m
         </strong>
         yelopathy,
         <strong>
          b
         </strong>
         ony deformities,
         <strong>
          a
         </strong>
         norectal malformations,
         <strong>
          a
         </strong>
         rterial anomalies, and
         <strong>
          r
         </strong>
         enal anomalies) syndrome. (See
         <a class="local">
          'LUMBAR syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Multiple hemangiomas
         </strong>
         – Infants younger than six months with ≥5 small cutaneous hemangiomas should undergo ultrasonography of the abdomen for potential liver hemangiomas and be monitored clinically. Older infants who are otherwise healthy do not require monitoring. (See
         <a class="local">
          'Multiple cutaneous hemangiomas'
         </a>
         above and
         <a class="local">
          'Hepatic hemangiomas'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet 2017; 390:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finn MC, Glowacki J, Mulliken JB. Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg 1983; 18:894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enjolras O, Mulliken JB. The current management of vascular birthmarks. Pediatr Dermatol 1993; 10:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 1998; 16:455.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubois J, Garel L, Grignon A, et al. Imaging of hemangiomas and vascular malformations in children. Acad Radiol 1998; 5:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paltiel HJ, Burrows PE, Kozakewich HP, et al. Soft-tissue vascular anomalies: utility of US for diagnosis. Radiology 2000; 214:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frieden IJ, Eichenfield LF, Esterly NB, et al. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol 1997; 37:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krowchuk DP, Frieden IJ, Mancini AJ, et al. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics 2019; 143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suh KY, Frieden IJ. Infantile hemangiomas with minimal or arrested growth: a retrospective case series. Arch Dermatol 2010; 146:971.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin JM, Sanchez S, González V, et al. Infantile hemangiomas with minimal or arrested growth: A retrospective case series. Pediatr Dermatol 2019; 36:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ma EH, Robertson SJ, Chow CW, Bekhor PS. Infantile Hemangioma with Minimal or Arrested Growth: Further Observations on Clinical and Histopathologic Findings of this Unique but Underrecognized Entity. Pediatr Dermatol 2017; 34:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corella F, Garcia-Navarro X, Ribe A, et al. Abortive or minimal-growth hemangiomas: Immunohistochemical evidence that they represent true infantile hemangiomas. J Am Acad Dermatol 2008; 58:685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valdivielso-Ramos M, Torrelo A, Martin-Santiago A, et al. Infantile hemangioma with minimal or arrested growth as the skin manifestation of PHACE syndrome. Pediatr Dermatol 2018; 35:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calderón-Castrat X, Peceros-Escalante J, Velásquez F, et al. Segmental Infantile Hemangioma With Minimal or Arrested Growth in LUMBAR Syndrome. Actas Dermosifiliogr 2017; 108:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Planas-Ciudad S, Roé Crespo E, Sánchez-Carpintero I, et al. Infantile hemangiomas with minimal or arrested growth associated with soft tissue hypertrophy: a case series of 10 patients. J Eur Acad Dermatol Venereol 2017; 31:1924.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esterly NB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr 1996; 26:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Samuelov L, Kinori M, Rychlik K, et al. Risk factors for ocular complications in periocular infantile hemangiomas. Pediatr Dermatol 2018; 35:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haggstrom AN, Lammer EJ, Schneider RA, et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006; 117:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Endicott AA, Chamlin SL, Drolet BA, et al. Mapping of Segmental and Partial Segmental Infantile Hemangiomas of the Face and Scalp. JAMA Dermatol 2021; 157:1328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 2002; 138:1567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metry DW, Hawrot A, Altman C, Frieden IJ. Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol 2004; 140:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J Pediatr 1997; 131:643.
          </a>
         </li>
         <li class="breakAll">
          PHACE association. Online Mendelian Inheritance in Man (OMIM). https://omim.org/entry/606519 (Accessed on May 24, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010; 126:e418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garzon MC, Epstein LG, Heyer GL, et al. PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations. J Pediatr 2016; 178:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metry DW, Garzon MC, Drolet BA, et al. PHACE syndrome: current knowledge, future directions. Pediatr Dermatol 2009; 26:381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Metry D, Heyer G, Hess C, et al. Consensus Statement on Diagnostic Criteria for PHACE Syndrome. Pediatrics 2009; 124:1447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003; 48:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldberg NS, Hebert AA, Esterly NB. Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol 1986; 122:684.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McAtee-Smith J, Hebert AA, Rapini RP, Goldberg NS. Skin lesions of the spinal axis and spinal dysraphism. Fifteen cases and a review of the literature. Arch Pediatr Adolesc Med 1994; 148:740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Albright AL, Gartner JC, Wiener ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989; 83:977.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tubbs RS, Wellons JC 3rd, Iskandar BJ, Oakes WJ. Isolated flat capillary midline lumbosacral hemangiomas as indicators of occult spinal dysraphism. J Neurosurg 2004; 100:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Girard C, Bigorre M, Guillot B, Bessis D. PELVIS Syndrome. Arch Dermatol 2006; 142:884.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schumacher WE, Drolet BA, Maheshwari M, et al. Spinal dysraphism associated with the cutaneous lumbosacral infantile hemangioma: a neuroradiological review. Pediatr Radiol 2012; 42:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iacobas I, Burrows PE, Frieden IJ, et al. LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies. J Pediatr 2010; 157:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stockman A, Boralevi F, Taïeb A, Léauté-Labrèze C. SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatology 2007; 214:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Drolet BA, Chamlin SL, Garzon MC, et al. Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin. J Pediatr 2010; 157:789.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sardana K, Gupta R, Garg VK, et al. A prospective study of cutaneous manifestations of spinal dysraphism from India. Pediatr Dermatol 2009; 26:688.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006; 118:882.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gnarra M, Behr G, Kitajewski A, et al. History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis. World J Clin Pediatr 2016; 5:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iacobas I, Phung TL, Adams DM, et al. Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring. J Pediatr 2018; 203:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rialon KL, Murillo R, Fevurly RD, et al. Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas. J Pediatr Surg 2015; 50:837.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dickie B, Dasgupta R, Nair R, et al. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg 2009; 44:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kulungowski AM, Alomari AI, Chawla A, et al. Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg 2012; 47:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ji Y, Chen S, Yang K, et al. Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: A multicenter prospective study. J Am Acad Dermatol 2021; 84:1378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horii KA, Drolet BA, Frieden IJ, et al. Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol 2011; 28:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: a twenty-seven-year experience. J Pediatr 1996; 129:346.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahon C, McHugh K, Alband N, et al. Routine liver ultrasound screening does not alter clinical management in a cohort study of multiple cutaneous infantile haemangioma. Br J Dermatol 2021; 184:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang SA, Tu HM, Harney JW, et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000; 343:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simsek E, Demiral M, Gundoğdu E. Severe consumptive hypothyroidism caused by multiple infantile hepatic haemangiomas. J Pediatr Endocrinol Metab 2018; 31:823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hughes JA, Hill V, Patel K, et al. Cutaneous haemangioma: prevalence and sonographic characteristics of associated hepatic haemangioma. Clin Radiol 2004; 59:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horii KA, Drolet BA, Baselga E, et al. Risk of hepatic hemangiomas in infants with large hemangiomas. Arch Dermatol 2010; 146:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garzon MC, Frieden IJ. Hemangiomas: when to worry. Pediatr Ann 2000; 29:58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Enjolras O, Mulliken JB, Boon LM, et al. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001; 107:1647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rogers M, Lam A, Fischer G. Sonographic findings in a series of rapidly involuting congenital hemangiomas (RICH). Pediatr Dermatol 2002; 19:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frieden IJ, Esterly NB. Pyogenic granulomas of infancy masquerading as strawberry hemangiomas. Pediatrics 1992; 90:989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider MH, Garcia CFV, Aleixo PB, Kiszewski AE. Congenital cutaneous pyogenic granuloma: Report of two cases and review of the literature. J Cutan Pathol 2019; 46:691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Browning JC, Eldin KW, Kozakewich HP, et al. Congenital disseminated pyogenic granuloma. Pediatr Dermatol 2009; 26:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brockman RM, Humphrey SR, Moe DC, et al. Mimickers of Infantile Hemangiomas. Pediatr Dermatol 2017; 34:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucas B, Ravishankar S, Pateva I. Pediatric Primary Hepatic Tumors: Diagnostic Considerations. Diagnostics (Basel) 2021; 11.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5793 Version 26.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28089471" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Infantile haemangioma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6663421" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Congenital vascular lesions: clinical application of a new classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8302734" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The current management of vascular birthmarks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9704205" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Diagnostic imaging in the evaluation of vascular birthmarks.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9597107" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Imaging of hemangiomas and vascular malformations in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10715041" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Soft-tissue vascular anomalies: utility of US for diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9344205" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30584062" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Clinical Practice Guideline for the Management of Infantile Hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20855695" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Infantile hemangiomas with minimal or arrested growth: a retrospective case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30318787" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Infantile hemangiomas with minimal or arrested growth: A retrospective case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27873347" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Infantile Hemangioma with Minimal or Arrested Growth: Further Observations on Clinical and Histopathologic Findings of this Unique but Underrecognized Entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18342717" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Abortive or minimal-growth hemangiomas: Immunohistochemical evidence that they represent true infantile hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29984853" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Infantile hemangioma with minimal or arrested growth as the skin manifestation of PHACE syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27939875" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Segmental Infantile Hemangioma With Minimal or Arrested Growth in LUMBAR Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28681397" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Infantile hemangiomas with minimal or arrested growth associated with soft tissue hypertrophy: a case series of 10 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8932511" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29766557" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Risk factors for ocular complications in periocular infantile hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16510649" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34550297" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Mapping of Segmental and Partial Segmental Infantile Hemangiomas of the Face and Scalp.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12472344" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15148105" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9386676" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9386676" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20643720" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Risk for PHACE syndrome in infants with large facial hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27659028" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : PHACE Syndrome: Consensus-Derived Diagnosis and Care Recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19689512" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : PHACE syndrome: current knowledge, future directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19858157" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Consensus Statement on Diagnostic Criteria for PHACE Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12664009" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Hemangiomas of infancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3717979" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Sacral hemangiomas and multiple congenital abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8019631" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Skin lesions of the spinal axis and spinal dysraphism. Fifteen cases and a review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2657627" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Lumbar cutaneous hemangiomas as indicators of tethered spinal cords.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14758934" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Isolated flat capillary midline lumbosacral hemangiomas as indicators of occult spinal dysraphism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16847205" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : PELVIS Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22138893" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Spinal dysraphism associated with the cutaneous lumbosacral infantile hemangioma: a neuroradiological review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20598318" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : LUMBAR: association between cutaneous infantile hemangiomas of the lower body and regional congenital anomalies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17191046" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20828712" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20199442" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : A prospective study of cutaneous manifestations of spinal dysraphism from India.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16950977" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27610342" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : History of the infantile hepatic hemangioma: From imaging to generating a differential diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30244993" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Guidance Document for Hepatic Hemangioma (Infantile and Congenital) Evaluation and Monitoring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25783331" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Risk factors for mortality in patients with multifocal and diffuse hepatic hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19159729" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Spectrum of hepatic hemangiomas: management and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22244411" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Lessons from a liver hemangioma registry: subtype classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33285272" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: A multicenter prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21517952" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8804322" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Hepatic vascular anomalies in infancy: a twenty-seven-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32767853" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Routine liver ultrasound screening does not alter clinical management in a cohort study of multiple cutaneous infantile haemangioma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10900278" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29953409" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Severe consumptive hypothyroidism caused by multiple infantile hepatic haemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15037141" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Cutaneous haemangioma: prevalence and sonographic characteristics of associated hepatic haemangioma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20157038" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Risk of hepatic hemangiomas in infants with large hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10941768" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Hemangiomas: when to worry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11391180" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11860561" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Sonographic findings in a series of rapidly involuting congenital hemangiomas (RICH).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1437442" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pyogenic granulomas of infancy masquerading as strawberry hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31095756" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Congenital cutaneous pyogenic granuloma: Report of two cases and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19706097" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Congenital disseminated pyogenic granuloma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28523875" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Mimickers of Infantile Hemangiomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33670452" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Pediatric Primary Hepatic Tumors: Diagnostic Considerations.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
